Rapid Response: Riding the Ozempic wave, w/RO's CEO Zach Reitano

Hero Product

Zach Reitano, CEO of Ro, shares the strategic decision to focus on obesity treatment as the company's hero product. This decision was driven by personal experiences and the potential to transform lives, as illustrated by his father's success with weight-loss drugs like Ozempic 1. Despite initial doubts within the organization, Reitano believed in the profound impact these treatments could have 2.

Building a brand is part art, part science. And. Cause if it was just pure science, everyone, everyone would be able to do it.

--- Zach Reitano

The choice to invest heavily in this direction was seen as a necessary step to establish Ro's brand identity and promise 2.

   

Refounding

Ro's journey to refound itself around obesity treatment involved significant restructuring and strategic pivots. Initially known for erectile dysfunction treatment under the brand Roman, Ro consolidated its offerings under one brand to align with its new focus 3. This shift required difficult decisions, including layoffs and the discontinuation of certain products, to narrow the company's focus and drive growth 3.

Building a company is a continuously humbling experience. You're constantly doing things where you're wrong.

--- Zach Reitano

The company also navigated challenges like drug shortages, which required innovative solutions to maintain patient care and satisfaction 4.